DrugPatentWatch Database Preview
Biogen Company Profile
Summary for Biogen
| Patents: | 206 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| BLAs: | 2 |
| Patent Litigation for Biogen: | See patent lawsuits for Biogen |
| PTAB Cases with Biogen as patent owner: | See PTAB cases with Biogen as patent owner |
US Patents for Biogen
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biogen Idec Inc | PLEGRIDY | peginterferon beta-1a | INJECTABLE;INJECTION | 125499 | 001 | 2014-08-15 | 9,474,688 | Corning Incorporated (Corning, NY) | ➤ Try a Free Trial | RX | search | |
| Biogen Idec Inc | PLEGRIDY | peginterferon beta-1a | INJECTABLE;INJECTION | 125499 | 001 | 2014-08-15 | 10,085,955 | Pathologica LLC (San Francisco, CA) | ➤ Try a Free Trial | RX | search | |
| Biogen Idec | TYSABRI | natalizumab | VIAL; SINGLE-USE | 125104 | 001 | 2004-11-23 | 9,995,752 | Children\'s Hospital Medical Center (Cincinnati, OH) Westfaelische Wilhelms-Universitaet Muenster (Muenster, DE) | ➤ Try a Free Trial | RX | search | |
| Biogen Idec | TYSABRI | natalizumab | VIAL; SINGLE-USE | 125104 | 001 | 2004-11-23 | 9,994,642 | Genentech, Inc. (South San Francisco, CA) | ➤ Try a Free Trial | RX | search | |
| Biogen Idec | TYSABRI | natalizumab | VIAL; SINGLE-USE | 125104 | 001 | 2004-11-23 | 9,993,568 | LegoChem Biosciences, Inc. (Daejeon, KR) | ➤ Try a Free Trial | RX | search | |
| Biogen Idec | TYSABRI | natalizumab | VIAL; SINGLE-USE | 125104 | 001 | 2004-11-23 | 9,977,036 | Schutzer; Steven E. (New York, NY) | ➤ Try a Free Trial | RX | search | |
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
Similar Applicant Names
Companies are sometimes listed under multiple names.
This search can help find similar names.
This search can help find similar names.
